RTW Investments’s Sage Therapeutics SAGE Stock Holding History

RTW Investments’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,002,370	Closed	-$16.3M	–	79
2024 Q4	$16.3M	Sell	3,002,370 -2,589,330	-46%	-$15.8M	0.25%	47
2024 Q3	$40.4M	Buy	5,591,700 +111,123	+2%	+$1.02M	0.58%	39
2024 Q2	$59.5M	Hold	5,480,577	–	–	0.92%	31
2024 Q1	$103M	Buy	5,480,577 +283,558	+5%	+$6.54M	1.52%	26
2023 Q4	$113M	Buy	5,197,019 +47,537	+0.9%	+$942K	1.76%	21
2023 Q3	$106M	Buy	+5,149,482	New	+$149M	2.24%	17
2019 Q1	–	Sell	-165,990	Closed	-$15.9M	–	53
2018 Q4	$15.9M	Buy	+165,990	New	+$19M	1.46%	20

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

TIG Advisors LLC New York $2.09B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return